Genetics Series: Updates in Pharmacogenetic Prescribing

Genetic variants can cause individuals to metabolize certain medications differently, depending on the type of metabolizer they are (poor, intermediate, extensive/normal, or ultrarapid). Pharmacogenetic testing is becoming widely utilized throughout healthcare and can aid in managing therapies for conditions involving anticoagulation, epilepsy, chronic pain, psychiatric disorders, and many more. This activity examines how genetics plays a role in drug metabolism and response, differences between metabolic phenotypes and activity scores, and how to apply prescribing recommendations to optimize the choice of medications that have clinical correlations to genomic variations.

Learning Objectives


At the conclusion of this activity, participants should be able to:

  • Explain how genetics plays a role in drug metabolism/response
  • Interpret clinical differences between metabolic phenotypes and activity scores
  • Utilize prescribing recommendations to optimize choice of medications that have clinical correlations to genomic variations

RELATED ACTIVITIES
Genetic Series
AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.